大多数试图重构护理交付的尝试从外部评估开始，该评估假设所需变革的规模，而不是测试当前归因和集成本是否能支持已签署的合同。 适用于医疗服务提供商的这个问题版本不是通用的。已经为38,000个生命接受了下行风险，却缺乏定价所需的分集成本数据——所以忽略分集成本的答案会自信地错误。分析必须从付款人组合和面板规模开始，而不是从收入开始。
大多数试图重构护理交付的尝试从外部评估开始，该评估假设所需变革的规模，而不是测试当前归因和集成本是否能支持已签署的合同。 适用于医疗服务提供商的这个问题版本不是通用的。已经为38,000个生命接受了下行风险，却缺乏定价所需的分集成本数据——所以忽略分集成本的答案会自信地错误。分析必须从付款人组合和面板规模开始，而不是从收入开始。
转型项目结合评估归因生命上损失的利润、选择要调整的面板或合同，以及部署运营转变。提供商将这些捆绑是因为初始审查以低成本提供以界定后续工作的范围，这为在付款人组合和面板运营上证明广泛干预创造了激励。
失败率仍然很高，因为从合同条款到项目计划的转换绕过了每提供者贡献与每集成本的计算，使变革顺序未锚定在实际决定合同绩效的因素上。
测试是CFO或医疗总监是否已经能列出面板规模或付款人组合的两三项调整以提升贡献，并附上每集成本。如果能，问题在于执行能力。如果不能，进一步在执行团队上的支出只会加深已接受风险与可用数据之间的不匹配。
公司战略与转型产生38,000个归因生命的成本分配，并识别哪些合同或面板在补贴其他，而不假设需要交付资源。当算术显示需要外部能力时，它明确说明范围，避免在未经测试的假设之后的第一轮发票。
这三者同时出现才是标志。单独一个通常指向其他问题。
✓ 合同被描述为覆盖归因生命，但尚未为这些人群计算集水平成本。
✓ 项目章程在任何提供者贡献分解存在之前概述工作流。
✓ 工作流围绕临床部门组织，而不是围绕具体的基于价值的合同缺口。
通常会让情况更糟的做法。 让同一家公司进行每集成本和付款人组合的初始审查，而该公司后来会提出要实施的变革量。
It is for you if you run or finance a healthcare provider and the word "transformation" is being used before anyone has agreed what is broken. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on 一家医疗服务提供商. It is a sample profile rather than a customer, and it is engine output translated from English — this is the format you get, on your own numbers.
The subject is Cedar Ridge Health Partners, a sample company profile used for testing rather than a customer — 38,000 attributed lives under value-based contracts.
Excerpt from a real Percision run · Pricing Strategy · sample company profile
The move. Protect and grow the 34% operating-income ASC engine by replacing retiring surgeons and steering 212k attributed lives to the ASC within 24 months.
| Investment required | $3.0-4.0M total over 24 months ($1.8-2.2M surgeon succession + retention bonuses; $1.2-1.8M referral-optimization platform and analytics) |
| Expected return | Incremental $4.8-6.4M annual ASC contribution margin by Month 24; payback 14-18 months on $3.0-4.0M investment; lifts group operating margin from 4.2% to 5.8-6.4%. |
| Revenue, year 1 | $202-208M (ASC case volume +4-6%) |
| Revenue, year 2 | $212-220M (ASC case volume +6-8%; physician retention +2-3%) |
| Revenue, year 3 | $225-235M (ASC contribution ≥40% of operating income) |
| Exit criteria | Strategy abandoned if, by Month 12, fewer than two qualified orthopaedic surgeon candidates have signed LOIs OR if ASC case volume has not grown at least 2% YoY; in either case, board must decide within 30 days whether to pivot to hospital-system sale process at 8-10× EBITDA. |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to 公司战略与转型, one of 29 engagements the platform runs. For 医疗服务提供商 it works through cost per episode, payer mix, panel size and contribution per provider, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. 在此阅读完整报告 if you would rather see the depth first.
对于中型市场公司，仅诊断阶段通常在六到十周内花费£75k–£250k，随后的交付阶段通常是其数倍。大公司日费率约为顾问£1,500–£3,500，合伙人£4,000–£8,000，典型团队混合两者，有效费率落在中间。但重要的数字不是日费率，而是诊断与交付的比例，因为那是范围设定的地方。
不能，任何声称相反的工具都在卖东西。软件无法运行项目办公室、与事业部总经理进行艰难对话，或提供九个月的四十人人力。它能做的是产生分析，决定是否需要那些东西，以及它们应指向何处——这是最常被匆忙处理且出错代价最高的部分。
将诊断与交付方分开购买，并在接受交付投标前写下决定。一旦两三项变革被命名且算术落于纸上，交付招标就是有固定简报的采购练习。一旦不是，招标就设定自己的简报，且总是更大的一个。
Materially, yes. Downside risk has been accepted on 38,000 lives without the cost-per-episode data needed to price it — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are cost per episode, payer mix, panel size, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on cost per episode and payer mix. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית